方 波,張 穎,馬 虹
(中國醫(yī)科大學(xué)附屬第一醫(yī)院麻醉科,遼寧 沈陽 110001)
miR-122a 對大鼠脊髓缺血/再灌注損傷后血-脊髓屏障的影響
方 波,張 穎,馬 虹
(中國醫(yī)科大學(xué)附屬第一醫(yī)院麻醉科,遼寧 沈陽 110001)
目的 探討miR-122a對脊髓缺血/再灌注損傷后血-脊髓屏障的影響。方法 SD大鼠36只,隨機(jī)分為3組:假手術(shù)組(S組)、對照組(C組)、miR-122a反義寡核苷酸(miR-122a antagomir)組(M組)。S組開胸游離主動脈弓,但不阻斷;C組和M組開胸阻斷主動脈弓14 min造成脊髓缺血/再灌注損傷。M組和C組脊髓缺血/再灌注損傷后,鞘內(nèi)注射miR-122a antagomir或空白對照,每日1次,共3次。Real-time PCR測定損傷節(jié)段脊髓組織的miR-122a表達(dá),Western blot測定脊髓組織中緊密連接蛋白o(hù)ccludin表達(dá),伊文思藍(lán)測定血-脊髓屏障通透性,Basso Beattie Bresnahan評分法評價神經(jīng)運動功能。結(jié)果 與S組比較,C組miR-122a表達(dá)增加,occludin表達(dá)減少,血-脊髓屏障通透性增加,神經(jīng)運動功能評分降低(P<0.05)。與C組比較,M組miR-122a表達(dá)降低,occludin表達(dá)增加,血-脊髓屏障通透性降低,神經(jīng)運動功能評分增加(P<0.05)。結(jié)論 miR-122a參與調(diào)控脊髓缺血/再灌注損傷后occludin表達(dá),影響血-脊髓屏障通透性。
缺血/再灌注損傷;脊髓;血-脊髓屏障;miR-122a;緊密連接蛋白;occludin
脊髓缺血/再灌注損傷是胸腹主動脈瘤手術(shù)最嚴(yán)重的并發(fā)癥,是急需攻克的難題。血-脊髓屏障破壞是脊髓損傷的重要繼發(fā)病理改變,而且進(jìn)一步加重脊髓損傷[1]。MicroRNA在轉(zhuǎn)錄后水平調(diào)控基因表達(dá),是目前研究基因治療和尋找藥物靶點的重要工具。最近研究證實,miR-122a介導(dǎo)緊密連接蛋白o(hù)ccludin 的mRNA降解增加腸道通透性[2-3]。有關(guān)miR-122a在脊髓損傷中的作用及可能的機(jī)制目前尚不清楚。本研究擬探討miR-122a對脊髓缺血/再灌注損傷后血-脊髓屏障的影響及其相關(guān)機(jī)制。
1.1 動物選擇與分組 SD大鼠36只,由中國醫(yī)科大學(xué)實驗動物中心提供,體質(zhì)量200~250 g。采用隨機(jī)數(shù)字表法,隨機(jī)分為3組(n=12):假手術(shù)組(S組)、對照組(C組)、miR-122a反義寡核苷酸(miR-122a antagomir)組(M組)。S組開胸游離主動脈弓,但不阻斷;C組和M組開胸阻斷主動脈弓14 min造成脊髓缺血/再灌注損傷。M組和C組在脊髓缺血/再灌注損傷后30 min鞘內(nèi)注射20 μL miR-122a antagomir(20 μmol·L-1,廣州銳博公司),每日注射1次,共3次。C組脊髓缺血/再灌注損傷后鞘內(nèi)注射等量miR-122a antagomir空白對照。實驗室光照時間6 ∶00~18 ∶00,溫度控制在18℃~22℃,造模后分籠飼養(yǎng),保證充足的水和食物。
1.2 脊髓缺血/再灌注損傷模型的建立 大鼠腹腔注射戊巴比妥鈉(40 mg·kg-1)麻醉,經(jīng)氣管切開處行氣管內(nèi)插管機(jī)械通氣。直腸內(nèi)置入溫度傳感器,持續(xù)監(jiān)測體溫,應(yīng)用電熱毯維持核心溫度(37.5±0.5) ℃。脊髓缺血/再灌注損傷模型參照文獻(xiàn)[4]制備。左頸總動脈置管測量近端動脈血壓,尾動脈置管測量遠(yuǎn)端血壓。擺右側(cè)臥位,于左前肢和肩胛下角間行橫切口,逐層分離暴露肋骨,于第2、3肋之間暴露胸腔,分離并顯露主動脈弓。皮下注射肝素(200 IU·kg-1),于左頸總動脈和左鎖骨下動脈之間夾閉主動脈,阻斷14 min后開放動脈夾,造成脊髓缺血/再灌注損傷。關(guān)胸,逐層縫合。術(shù)后將動物放置28℃的保溫箱內(nèi),等待動物蘇醒后回籠飼養(yǎng)。
1.3 Real-time PCR 脊髓缺血/再灌注損傷后72 h,取新鮮缺血節(jié)段脊髓組織,根據(jù)TRIzol操作說明,提取細(xì)胞總RNA。提取的總RNA定量后,對于蛋白編碼基因使用Oligo(dT)作為逆轉(zhuǎn)錄引物,對于miRNA使用miRNA特異的逆轉(zhuǎn)錄引物,使用反轉(zhuǎn)錄試劑盒合成cDNA第一鏈。使用適量的cDNA作為PCR模板,MX3000P Real-time PCR 擴(kuò)增儀進(jìn)行PCR 反應(yīng),SYBR染料實時檢測擴(kuò)增產(chǎn)物的量,以GAPDH為內(nèi)參分析蛋白編碼基因表達(dá)情況,以U6 為內(nèi)參分析miRNA的表達(dá)情況。所使用引物序列如下:U6 上游引物5′-CTCGCTTCGGCAGCACA-3′,U6下游引物5′-AACGCTTCACGAATTTGCGT-3′;GAPDH上游引物5′-TCAACGACCACTTTGTCAAGCTCA-3′,GAPDH下游引物5′-GCTGGTGGTCCAGGGGTCTTACT-3′。
1.4 Western blot 脊髓缺血/再灌注損傷后72 h,取新鮮缺血節(jié)段脊髓組織,迅速液氮冷凍保存。標(biāo)本取齊后,剪碎,加組織裂解液,冰上勻漿,4℃離心15 min,取其上清液,BCA法蛋白定量,經(jīng)電泳、轉(zhuǎn)膜、醋酸纖維素膜包被后,加入兔抗大鼠occludin一抗(1 ∶500,Invitrogen公司),4℃孵育過夜,加入HRP標(biāo)記的羊抗兔 IgG二抗,室溫孵育2 h,TBST沖洗,化學(xué)發(fā)光,凝膠成像系統(tǒng)拍攝。采用Image-Pro Plus 6.0圖像分析軟件對其進(jìn)行半定量分析。
1.5 血-脊髓屏障通透性測定 脊髓缺血/再灌注損傷后72 h,經(jīng)鼠尾靜脈緩慢注射2% 伊文思藍(lán)10 mL·kg-1,1 h后麻醉,經(jīng)左心室灌注生理鹽水500 mL·kg-1,取出脊髓缺血節(jié)段(L4-6),迅速放入40 g·L-1多聚甲醛中,24 h后依次置于150、200、300 g·L-1的蔗糖中沉糖,沉糖完畢后包埋,冰凍切片,置于熒光顯微鏡綠色激光下觀察。依照熒光光斑的大小、疏密、強(qiáng)弱來評價脊髓組織中伊文思藍(lán)外滲量。
1.6 大鼠神經(jīng)運動功能評價 采用Basso Beattie Bresnahan(BBB)評分標(biāo)準(zhǔn)對大鼠下肢運動神經(jīng)功能進(jìn)行評價。
2.1 Real-time PCR檢測脊髓組織中miR-122a表達(dá) 與S組(1.00±0.07)相比,C組miR-122a表達(dá)(3.78±0.46)增高(P<0.05);與C組相比,M組miR-122a表達(dá)(1.74±0.27)降低(P<0.05),F(xiàn)ig 1。
Fig 1 miR-122a expression at 72 h after spinal
S:Sham; C: control; M:miR-122a antagomir.*P<0.05vsS group;#P<0.05vsC group
2.2 Western blot 檢測脊髓組織中occludin表達(dá) 與S組(1.00±0.06)相比,C組occludin表達(dá)(0.28±0.04)降低(P<0.05);與C組相比,M組occludin表達(dá)(0.55±0.06)增加(P<0.05),F(xiàn)ig 2。
Fig 2 Occludin expression at 72 h after spinal
S:Sham; C: control; M:miR-122a antagomir.*P<0.05vsS group;#P<0.05vsC group
2.3 血-脊髓屏障通透性 脊髓缺血/再灌注損傷后,血-脊髓屏障破壞,通透性增加,與S組(1.00±0.08)相比,C組伊文思藍(lán)外滲量(6.12±0.73)增加(P<0.05);與C組相比,M組伊文思藍(lán)外滲量(3.24±0.38)減少(P<0.05),F(xiàn)ig 3。
Fig 3 Permeability of blood-spinal cord barrier at
A:Evans blue extravasation fluorescence;B:Quantitative analysis of evans blue extravasation.S:Sham; C: control; M:miR-122a antagomir.*P<0.05vsS group;#P<0.05vsC group
2.4 大鼠神經(jīng)運動功能 與S組(21.0±0.0)比較,C組BBB評分(7.2±1.1)降低(P<0.05);與 C組比較,M組BBB評分(13.7±2.8)增高(P<0.05),F(xiàn)ig 4。
S:Sham; C: control; M:miR-122a antagomir.*P<0.05vsS group;#P<0.05vsC group
脊髓缺血/再灌注損傷是胸腹主動脈瘤手術(shù)最嚴(yán)重的并發(fā)癥之一,可引起脊髓功能障礙,甚至截癱。血-脊髓屏障與血-腦屏障相似,是一個復(fù)雜的細(xì)胞系統(tǒng),調(diào)節(jié)脊髓液體微環(huán)境在較小的范圍內(nèi)波動,對維持中樞神經(jīng)系統(tǒng)的內(nèi)環(huán)境穩(wěn)定起著非常重要的作用[5]。脊髓缺血/再灌注損傷后,血-脊髓屏障完整性破壞,通透性增加,造成脊髓組織水腫、炎癥以及神經(jīng)元凋亡,進(jìn)一步加重脊髓損傷[6-9]。緊密連接是血-脊髓屏障的結(jié)構(gòu)和功能基礎(chǔ),occludin是第一個被分離出的組成緊密連接的完整膜蛋白,主要參與微血管內(nèi)皮細(xì)胞間緊密連接的形成。研究發(fā)現(xiàn),脊髓缺血/再灌注損傷后occludin表達(dá)減少,導(dǎo)致血-脊髓屏障通透性增加[10],但其機(jī)制尚不完全明確。
MicroRNA屬于調(diào)控RNA家族一員。當(dāng)非編碼小RNA與靶mRNA完全或不完全配對時,可引起mRNA降解,或發(fā)生在mRNA水平上誘導(dǎo)特異性序列基因表達(dá)部分或完全抑制的過程[11]。miR-122a作為肝臟特異性高表達(dá)的microRNA,對其研究多集中在肝癌的發(fā)生發(fā)展中[12-13]。最近研究表明,miR-122a也負(fù)向調(diào)控緊密連接蛋白o(hù)ccludin的表達(dá)[2,3,14],參與內(nèi)皮細(xì)胞通透性調(diào)節(jié),影響病理生理功能。
本研究發(fā)現(xiàn),脊髓缺血/再灌注損傷后miR-122a表達(dá)上調(diào),同時伴隨occludin表達(dá)減少,血-脊髓屏障破壞。反義寡核苷酸在miRNA 功能研究中是沉默miRNA的最常用,且行之有效的方法[15]。本研究鞘內(nèi)注射miR-122a antagomir抑制了miR-122a表達(dá),而且增加occludin表達(dá),減輕血-脊髓屏障破壞,改善大鼠神經(jīng)運動功能。
綜上所述,miR-122a在脊髓缺血/再灌注損傷中通過調(diào)控血-脊髓屏障緊密連接蛋白o(hù)ccludin,進(jìn)而發(fā)揮重要的作用。將其作為靶點,將為預(yù)防和治療脊髓損傷提供新思路。
(致謝:本實驗在中國醫(yī)科大學(xué)附屬第一醫(yī)院實驗中心、麻醉科實驗室完成,在此特對以上實驗室和實驗過程中給予指導(dǎo)和幫助的老師表示感謝!)
[1] Sharma H S.Pathophysiology of blood-spinal cord barrier in traumatic injury and repair[J].CurrPharmDes,2005,11 (11):1353-89.
[2] Ye D, Guo S, Al-Sadi R, et al. MicroRNA regulation of intestinal epithelial tight junction permeability[J].Gastroenterology, 2011, 141(4):1323-33.
[3] Zhao H,Zhao C,Dong Y,et al. Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occluding expression and protects mice from alcoholic liver disease[J].ToxicolLett,2015,234(3):194-200.
[4] Award H, Ankeny D P, Guan Z, et al. A mouse model of ischemic spinal cord injury with delayed paralysis caused by aortic cross-clamping[J].Anesthesiology, 2010, 113(4):880-91.
[5] Maikos J T,Shreiber D I.Immediate damage to the blood-spinal cord barrier due to mechanical trauma[J].JNeurotrauma,2007,24(3):492-507.
[6] Fang B, Li X M, Sun X J, et al. Ischemic preconditioning protects against spinal cord ischemia-reperfusion injury in rabbits by attenuating blood spinal cord barrier disruption[J].IntJMolSci,2013,14(5):10343-54.
[7] Li X Q, Wang J, Fang B,et al. Intrathecal antagonism of microglial TLR4 reduces inflammatory damage to blood-spinal cord barrier following ischemia/reperfusion injury in rats[J].MolBrain,2014,7(28).doi:10.1186/1756-6606-7-28.
[8] Fang B, Li X Q, Bi B, et al. Dexmedetomidine attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia reperfusion injury in rats[J].CellPhysiolBiochem,2015,36(1):373-83.
[9] 方 波, 孫學(xué)軍, 王 赫, 等. 鞘內(nèi)移植骨髓基質(zhì)細(xì)胞對兔脊髓缺血/再灌注損傷早期水通道蛋白-4表達(dá)的影響[J]. 中國藥理學(xué)通報,2013,29(4): 478-81.
[9] Fang B, Sun X J, Wang H, et al. Effects of intrathecal transplantation of bone marrow stromal cells on aquaporin-4 expression in spinal cord following spinal ischemia-reperfusion injury in rabbits[J].ChinPharmacolBull,2013,29(4): 478-81.
[10]Fang B, Wang H, Sun X J, et al. Intrathecal transplantation of bone marrow stromal cells attenuates blood spinal cord barrier disruption induced by spinal cord ischemia reperfusion injury in rabbits[J].JVascSurg, 2013,8(4):1043-52.
[11]Vriens M R, Weng J, Suh I, et al. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer[J].Cancer,2012,118(13):3426-32.
[12]Bai S, Nasser M W, Wang B, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib[J].JBiolChem, 2009, 284(46):32015-27.
[13]Lin C J, Gong H Y, Tseng H C, et al. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines[J].BiochemBiophysResCommun, 2008, 375(3):315-20.
[14]馬 騰, 劉麗波, 王 萍, 等. 血腦屏障氧糖剝奪體外模型大鼠腦微血管內(nèi)皮細(xì)胞miRNA表達(dá)變化[J]. 解剖科學(xué)進(jìn)展, 2011, 17(2):128-30.
[14]Ma T, Liu L B, Wang P, et al. Changes of miRNA expression profiles in cultured brain microvascular endothelium of rat with blood brain barrier for oxygen glucose deprivation[J].ProgAnatomSci,2011,17(2): 128-30.
[15]夏 新, 張小敏, 宋鵬飛, 等. 反義寡核苷酸介導(dǎo)的miRNA 沉默研究[J]. 安徽農(nóng)業(yè)科學(xué),2011,39(24):14545-7.
[15]Xia X, Zhang X M, Song P F, et al. Study of miRNA silencing mediated by antisense oligonucleotide[J].JAnhuiAgricSci,2011,39(24):14545-7.
Effects of miR-122a on blood-spinal cord barrier after spinal cord ischemia-reperfusion injury in rats
FANG Bo,ZHANG Ying,MA Hong
(DeptofAnesthesiology,theFirstHospitalofChinaMedicalUniversity,Shenyang110001,China)
Aim To investigate the effects of miR-122a on blood-spinal cord barrier after spinal cord ischemia-reperfusion injury in rats.Methods Thirty-six SD rats were randomly divided into three groups:group of sham(S group), group of control(C group) and group of miR-122a antagomir(M group). Rats in S group were subjected to exposure of aorta arch but without occlusion. Spinal ischemia-reperfusion injury was induced by clamping the aorta arch for 14 min in C group and M group. Rats in M group and C group were intrathecally injected with miR-122a antagomir or antagomir control daily for three times after injury. The miR-122a expression in injured spinal cord tissue was detected by real-time PCR. The occludin expression in injured spinal cord tissue was detected by Western blot. The permeability of blood-spinal cord barrier was examined using evans blue as a vascular tracer. The neurological motor function was evaluated by Basso Beattie Bresnahan score.Results Compared with S group, the expression of miR-122a was increased, the expression of occludin was decreased, the permeability of blood-spinal cord barrier was increased, and neurological motor function score was decreased significantly in C group(P<0.05). Compared with C group, the expression of miR-122a was decreased, the expression of occludin was increased, the permeability of blood-spinal cord barrier was decreased, and neurological motor function score was increased significantly in M group(P<0.05).Conclusion miR-122a can regulate the expression of occludin and change the permeability of blood-spinal cord barrier.
ischemia-reperfusion injury;spinal cord;blood-spinal cord barrier;miR-122a;tight junction protein;occludin
2016-12-19,
2017-01-25
遼寧省博士科研啟動基金項目( No 20141035); 國家自然科學(xué)基金資助項目(No 81401000)
方 波(1979-),男,博士,副教授,碩士生導(dǎo)師,研究方向:圍術(shù)期中樞神經(jīng)系統(tǒng)保護(hù),通訊作者,Tel:024-83283100,E-mail:drunk0630@126.com
時間:2017-4-24 11:20
http://kns.cnki.net/kcms/detail/34.1086.R.20170424.1120.044.html
10.3969/j.issn.1001-1978.2017.05.022
A
1001-1978(2017)05-0703-04
R-332;R322.81;R341;R342.4;R619.9